FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057482589> ?p ?o ?g. }

• W2057482589 endingPage "867" @default.
• W2057482589 startingPage "861" @default.
• W2057482589 abstract "Due to serious adverse effects and the limited effectiveness of currently available pharmacological therapies for obesity, many research efforts have focused on the development of drugs from natural products. Our previous studies demonstrated that berberine, an alkaloid originally isolated from traditional Chinese herbs, prevented fat accumulation in vitro and in vivo. In this pilot study, obese human subjects (Caucasian) were given 500 mg berberine orally three times a day for twelve weeks. The efficacy and safety of berberine treatment was determined by measurements of body weight, comprehensive metabolic panel, blood lipid and hormone levels, expression levels of inflammatory factors, complete blood count, and electrocardiograph. A Sprague-Dawley rat experiment was also performed to identify the anti-obesity effects of berberine treatment. The results demonstrate that berberine treatment produced a mild weight loss (average 5 lb/subject) in obese human subjects. But more interestingly, the treatment significantly reduced blood lipid levels (23% decrease of triglyceride and 12.2% decrease of cholesterol levels) in human subjects. The lipid-lowering effect of berberine treatment has also been replicated in the rat experiment (34.7% decrease of triglyceride and 9% decrease of cholesterol level). Cortisol, calcitriol, ACTH, TSH, FT4, and SHBG levels were not significantly changed following 12 weeks of berberine treatment. However, there was interestingly, an increase in calcitriol levels seen in all human subjects following berberine treatment (mean 59.5% increase, p = 0.11). Blood inflammatory factors (CRP, IL-6, TNFα, COX-2) and erythrocyte sedimentation rate (ESR) were not significantly affected by treatment with berberine. Tests of hematological, cardiovascular, liver, and kidney function following berberine treatment showed no detrimental side effects to this natural compound. Collectively, this study demonstrates that berberine is a potent lipid-lowering compound with a moderate weight loss effect, and may have a possible potential role in osteoporosis treatment/prevention." @default.
• W2057482589 created "2016-06-24" @default.
• W2057482589 creator A5003938606 @default.
• W2057482589 creator A5004902784 @default.
• W2057482589 creator A5007702706 @default.
• W2057482589 creator A5010809013 @default.
• W2057482589 creator A5022439223 @default.
• W2057482589 creator A5031122943 @default.
• W2057482589 creator A5034271021 @default.
• W2057482589 creator A5037316500 @default.
• W2057482589 creator A5044602512 @default.
• W2057482589 creator A5050915074 @default.
• W2057482589 creator A5054897108 @default.
• W2057482589 creator A5057212703 @default.
• W2057482589 creator A5062421744 @default.
• W2057482589 creator A5064150028 @default.
• W2057482589 creator A5074889368 @default.
• W2057482589 creator A5091095904 @default.
• W2057482589 date "2012-07-01" @default.
• W2057482589 modified "2023-10-13" @default.
• W2057482589 title "Lipid-lowering effect of berberine in human subjects and rats" @default.
• W2057482589 cites W1969395627 @default.
• W2057482589 cites W1973852095 @default.
• W2057482589 cites W1978180139 @default.
• W2057482589 cites W1983674364 @default.
• W2057482589 cites W1987643123 @default.
• W2057482589 cites W2005188727 @default.
• W2057482589 cites W2009141930 @default.
• W2057482589 cites W2017097013 @default.
• W2057482589 cites W2017742158 @default.
• W2057482589 cites W2018243224 @default.
• W2057482589 cites W2030646575 @default.
• W2057482589 cites W2037458226 @default.
• W2057482589 cites W2040735329 @default.
• W2057482589 cites W2045025102 @default.
• W2057482589 cites W2054362555 @default.
• W2057482589 cites W2055701798 @default.
• W2057482589 cites W2073338945 @default.
• W2057482589 cites W2076903615 @default.
• W2057482589 cites W2091708838 @default.
• W2057482589 cites W2111186212 @default.
• W2057482589 cites W2115692828 @default.
• W2057482589 cites W2130478732 @default.
• W2057482589 cites W2133741030 @default.
• W2057482589 cites W2135424573 @default.
• W2057482589 cites W2143879543 @default.
• W2057482589 cites W2147542963 @default.
• W2057482589 cites W2151039642 @default.
• W2057482589 cites W2166797518 @default.
• W2057482589 doi "https://doi.org/10.1016/j.phymed.2012.05.009" @default.
• W2057482589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22739410" @default.
• W2057482589 hasPublicationYear "2012" @default.
• W2057482589 type Work @default.
• W2057482589 sameAs 2057482589 @default.
• W2057482589 citedByCount "94" @default.
• W2057482589 countsByYear W20574825892013 @default.
• W2057482589 countsByYear W20574825892014 @default.
• W2057482589 countsByYear W20574825892015 @default.
• W2057482589 countsByYear W20574825892016 @default.
• W2057482589 countsByYear W20574825892017 @default.
• W2057482589 countsByYear W20574825892018 @default.
• W2057482589 countsByYear W20574825892019 @default.
• W2057482589 countsByYear W20574825892020 @default.
• W2057482589 countsByYear W20574825892021 @default.
• W2057482589 countsByYear W20574825892022 @default.
• W2057482589 countsByYear W20574825892023 @default.
• W2057482589 crossrefType "journal-article" @default.
• W2057482589 hasAuthorship W2057482589A5003938606 @default.
• W2057482589 hasAuthorship W2057482589A5004902784 @default.
• W2057482589 hasAuthorship W2057482589A5007702706 @default.
• W2057482589 hasAuthorship W2057482589A5010809013 @default.
• W2057482589 hasAuthorship W2057482589A5022439223 @default.
• W2057482589 hasAuthorship W2057482589A5031122943 @default.
• W2057482589 hasAuthorship W2057482589A5034271021 @default.
• W2057482589 hasAuthorship W2057482589A5037316500 @default.
• W2057482589 hasAuthorship W2057482589A5044602512 @default.
• W2057482589 hasAuthorship W2057482589A5050915074 @default.
• W2057482589 hasAuthorship W2057482589A5054897108 @default.
• W2057482589 hasAuthorship W2057482589A5057212703 @default.
• W2057482589 hasAuthorship W2057482589A5062421744 @default.
• W2057482589 hasAuthorship W2057482589A5064150028 @default.
• W2057482589 hasAuthorship W2057482589A5074889368 @default.
• W2057482589 hasAuthorship W2057482589A5091095904 @default.
• W2057482589 hasConcept C124490489 @default.
• W2057482589 hasConcept C126322002 @default.
• W2057482589 hasConcept C134018914 @default.
• W2057482589 hasConcept C139572402 @default.
• W2057482589 hasConcept C185592680 @default.
• W2057482589 hasConcept C197934379 @default.
• W2057482589 hasConcept C2776079296 @default.
• W2057482589 hasConcept C2777667214 @default.
• W2057482589 hasConcept C2778163477 @default.
• W2057482589 hasConcept C2778270857 @default.
• W2057482589 hasConcept C2778913445 @default.
• W2057482589 hasConcept C2780116568 @default.
• W2057482589 hasConcept C511355011 @default.
• W2057482589 hasConcept C71240020 @default.
• W2057482589 hasConcept C71924100 @default.

• next